| Serial Number | 98748841 |
| Word Mark | CRYPTOMAP |
| Filing Date | Friday, September 13, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 3, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 3, 2025 |
| Goods and Services | Pharmaceutical products and preparations for the treatment of cancer; pharmaceutical products and preparations for the prevention of cancer; vaccines; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; immunoassay reagents for medical use; proteins with diagnostic and therapeutic uses, namely, protein arrays for medical diagnosis purposes; diagnostic reagents for medical use; diagnostic and testing preparations for clinical, medical and medical laboratory use, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in oncology and immunology testing for medical purposes; diagnostic test kits for medical purposes, namely, diagnostic kits comprising diagnostic agents, preparations and substances for medical use; antibodies for medical purposes; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use |
| Pseudo Mark | CRYPTO MAP |
| Goods and Services | Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; chemicals, reagents and substances, being diagnostic reagents, buffers, nucleic acids, peptides, antibodies and immunological peptides for medical research; antibodies for scientific purposes; immunoassay reagents, other than for medical or veterinary use; diagnostic preparations and reagents for scientific or research use; test kits for scientific or research use composed primarily of nucleic acids, peptides, antibodies, buffers and reagents; proteins, namely, monoclonal and polyclonal antibodies, and immunological peptides for scientific or research use; nucleotides for scientific and research use |
| Goods and Services | Services in the field of oncology and immunology, namely, medical analysis services for the diagnosis of cancer and immunological disorders; medical screening services in the fields of oncology and immunology. |
| Goods and Services | Research and development in the fields of medicine in the nature of oncology and immunology; scientific research for medical purposes in the field of oncology; mining in the field of biology; biological research services; pharmaceutical research services; analysis of human tissues for medical research; drug discovery services; provision of information and data on oncology and immunology; biomedical research services conducted using databases; consultancy, information and advisory services in the fields of oncology and immunology |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 13, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 13, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 13, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 13, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Epitopea Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge CB12LA GB |
| Party Name | Epitopea Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Montreal, Quebec H3T1J4 CA |
| Party Name | Epitopea Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge CB12LA GB |
| Party Name | Epitopea Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Montreal, Quebec H3T1J4 CA |
| Event Date | Event Description |
| Friday, September 13, 2024 | NEW APPLICATION ENTERED |
| Friday, January 24, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 13, 2025 | ASSIGNED TO EXAMINER |
| Friday, March 21, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, March 21, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, March 21, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 25, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, April 25, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Friday, April 25, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, April 25, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, April 25, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, April 25, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, April 25, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, April 25, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 9, 2025 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Friday, April 25, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 28, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 3, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 3, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |